Ticagrelor versus clopidogrel in acute coronary syndromes [4]

New England Journal of Medicine

Volumn 361, Issue 24, 2009, Pages 2386-2387

  Wartak, Siddharth A ^a   Lotfi, Amir ^a   Rothberg, Michael ^a  

^a BAYSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PRASUGREL; TICAGRELOR; ADENOSINE; ANTITHROMBOCYTIC AGENT; DRUG DERIVATIVE; PURINERGIC P2 RECEPTOR; TICLOPIDINE;

ACUTE CORONARY SYNDROME; BLEEDING; BLOOD TRANSFUSION; CLINICAL TRIAL; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; INCIDENCE; LETTER; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RISK ASSESSMENT; CHEMICALLY INDUCED DISORDER; CORONARY ARTERY BYPASS GRAFT; DRUG ANTAGONISM; HEART INFARCTION; MORTALITY; NOTE; STROKE; METHODOLOGY;

ACUTE CORONARY SYNDROME; ADENOSINE; CORONARY ARTERY BYPASS; HEMORRHAGE; HUMANS; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; RECEPTORS, PURINERGIC P2; STROKE; TICLOPIDINE; RESEARCH DESIGN;

EID: 71849094942     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: None     Document Type: Letter

References (3)

1. The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494-502. [Errata, N Engl J Med 2001;345:1506, 1716.]
2. Wiviott SD, Braunwald E, McCabe CH, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2007;357:2001-2015 (Pubitemid 350106708)
3. Ferguson JJ, Califf RM, Antman EM, et al. Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial. JAMA 2004;292:45-54. (Pubitemid 38923793)